Eine Explorative Studie, um die Sicherheit, Akzeptanz und das vaginale Blutungsprofil von drei Etonogestrel-freisetzenden intrauterinen Systemen (Studie P06060) zu untersuchen

Kurzzusammenfassung

This is a phase 2, randomized, active-controlled, parallel-group, multicenter, single-blind trial of three different doses of etonogestrel releasing medicated intrauterine systems (ENG-MIUS) in healthy parous women in need for contraception. The primary trial objective is to explore safety and acceptability of three doses of an ENG-releasing medicated intrauterine system (ENG-MIUS) as compared to Multiload-cu 375®.